30-day FRN

12617

Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of collection

Average
burden per
response
(in hours)

Number of
responses per
respondent

Total burden
hours

Surveys ............................................................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ..................................
Focus Groups ..................................................................................................
Website or Software Usability Tests ................................................................

10,000
500
1,000
5,000

1
1
1
1

30/60
90/60
90/60
20/60

5,000
750
1,500
1,667

Total ..........................................................................................................

16,500

16,500

........................

8,917

Dated: February 15, 2017.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; NCI Genomic Data
Commons (GDC) Data Submission
Request Form (National Cancer
Institute)
National Institutes of Health,

HHS.
ACTION:

Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
[email protected] or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Louis M. Staudt,
MD, Ph.D., Director, Center for Cancer
Genomics, National Cancer Institute,
Building 10, Room 5A02, 10 Center
Drive, Bethesda, MD 20814 or call nontoll-free number 301–402–1892 or Email
your request, including your address to:
[email protected].
SUPPLEMENTARY INFORMATION: The
National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
ADDRESSES:

[FR Doc. 2017–04254 Filed 3–3–17; 8:45 am]

AGENCY:

to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: NCI Genomic
Data Commons (GDC) Data Submission
Request Form, 0925-New, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The purpose of the NCI
Genomic Data Commons (GDC) Data
Submission Request Form is to provide
a vehicle for investigators to request
submission of their cancer genomic data
into the GDC in support of data sharing.
The purpose is to also provide a
mechanism for the GDC Data
Submission Review Committee to
review and assess the data submission
request for applicability to the GDC
mission. The scope of the form involves
obtaining information from investigators
that: (1) Would like to submit data about
their study into the GDC, (2) are
affiliated with studies that adhere to
GDC data submission conditions. The
benefits of the collection are that it
provides the needed information for
investigators to understand the types of
studies and data that the GDC supports,
and that it provides a standard
mechanism for the GDC to assess
incoming data submission requests.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
50 hours.

of having their full effect if received
within 30-days of the date of this
publication.

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below. This proposed
information collection was previously
published in the Federal Register on
Tuesday, November 8, 2016 page 78609
Vol. 81 No. 216 FR 78609 and allowed
60 days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
DATES: Comments regarding this
information collection are best assured
SUMMARY:

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

asabaliauskas on DSK3SPTVN1PROD with NOTICES

Type of respondent

Number of
responses per
respondent

Investigator (19–1040 Medical Scientists) .......................................................

200

1

Total ..........................................................................................................

200

200

VerDate Sep<11>2014

19:24 Mar 03, 2017

Jkt 241001

PO 00000

Frm 00085

Fmt 4703

Sfmt 4703

E:\FR\FM\06MRN1.SGM

06MRN1

Average
time per
response
(in hours)
15/60

Total annual
burden hour
50
50

12618

Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices

Dated: February 15, 2017.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
[FR Doc. 2017–04255 Filed 3–3–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings

asabaliauskas on DSK3SPTVN1PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
appications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–14–
255: Multidisciplinary Studies of HIV and
Viral Hepatitis Co-Infection.
Date: March 28, 2017.
Time: 10:00 a.m. to 11:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Physiology and Pathobiology of
Musculoskeletal, Oral and Skin Systems.
Date: March 29, 2017.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Anshumali Chaudhari,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
MSC 7802, Bethesda, MD 20892, (301) 435–
1210, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Non-HIV Diagnostics, Food Safety,
Sterilization/Disinfection and
Bioremediation.
Date: March 30–31, 2017.

VerDate Sep<11>2014

19:24 Mar 03, 2017

Jkt 241001

Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Rm 3200, MSC 7808,
Bethesda, MD 20892, 301–435–1167,
[email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Cancer Biotherapeutics
Development.
Date: March 30–31, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Nicholas J. Donato, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040,
Bethesda, MD 20817, 301–827–4810,
[email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA–GM–
17–004: Maximizing Investigators’ Research
Award for Early Stage Investigators (R35).
Date: March 30, 2017.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: David Balasundaram,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892, 301–435–
1022, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Cardiovascular Science.
Date: March 30–31, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kimm Hamann, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118A,
MSC 7814, Bethesda, MD 20892, 301–435–
5575, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 28, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04172 Filed 3–3–17; 8:45 am]
BILLING CODE 4140–01–P

PO 00000

Frm 00086

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel, NCCIH Training,
Career Development, Fellowship, and
Research Grant Review.
Date: March 22, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Ashlee Tipton, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Center for
Complementary and Integrative Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892, 301–451–3849, Ashlee.tipton@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Integrative Health,
National Institutes of Health, HHS)
Dated: February 28, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04177 Filed 3–3–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; CTEP Support
Contracts Forms and Surveys, NCI,
NIH
AGENCY:

National Institutes of Health,

HHS.
ACTION:

E:\FR\FM\06MRN1.SGM

Notice.

06MRN1